Margalit B. Mokyr

Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice.

Margalit B. Mokyr, T. V. Kalinichenko, L Gorelik et al. · PubMed · 1998 · 130 citations

Therapeutic Potential, Chemotherapeutic Agent Melphalan, Immunology +23

Activation of suppressor T cells by tumour cells and specific antibody

Richard K. Gershon, Margalit B. Mokyr, Malcolm S. Mitchell · Nature · 1974 · 118 citations

Tumor Immunology, Cancer Immunosurveillance, T-regulatory Cell +13

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.

James C. D. Hengst, Margalit B. Mokyr, Sheldon Dray · PubMed · 1981 · 100 citations

Immunology, Immunoediting, Metronomic Chemotherapy +17

Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression.

Vladimir V. Kalinichenko, Margalit B. Mokyr, Lloyd H. Graf et al. · PubMed · 1999 · 92 citations

T-regulatory Cell, Immunology, Immune Regulation +17

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.

James C. D. Hengst, Margalit B. Mokyr, Sheldon Dray · PubMed · 1980 · 92 citations

Mopc-315 Tumor-bearing Mice, Immunology, Immunotherapeutics +19